These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8425756)

  • 41. The search for the familial breast/ovarian cancer gene.
    Black DM; Solomon E
    Trends Genet; 1993 Jan; 9(1):22-6. PubMed ID: 8434413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families.
    Seitz S; Rohde K; Bender E; Nothnagel A; Kölble K; Schlag PM; Scherneck S
    Oncogene; 1997 Feb; 14(6):741-3. PubMed ID: 9038382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Linkage of early-onset familial breast cancer to chromosome 17q21.
    Hall JM; Lee MK; Newman B; Morrow JE; Anderson LA; Huey B; King MC
    Science; 1990 Dec; 250(4988):1684-9. PubMed ID: 2270482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21.
    Steichen-Gersdorf E; Gallion HH; Ford D; Girodet C; Easton DF; DiCioccio RA; Evans G; Ponder MA; Pye C; Mazoyer S
    Am J Hum Genet; 1994 Nov; 55(5):870-5. PubMed ID: 7977348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
    Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS
    J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.
    Saito H; Inazawa J; Saito S; Kasumi F; Koi S; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
    Cancer Res; 1993 Jul; 53(14):3382-5. PubMed ID: 8100738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-density genetic map of the BRCA1 region of chromosome 17q12-q21.
    Anderson LA; Friedman L; Osborne-Lawrence S; Lynch E; Weissenbach J; Bowcock A; King MC
    Genomics; 1993 Sep; 17(3):618-23. PubMed ID: 8244378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolated familial somatotropinomas: establishment of linkage to chromosome 11q13.1-11q13.3 and evidence for a potential second locus at chromosome 2p16-12.
    Gadelha MR; Une KN; Rohde K; Vaisman M; Kineman RD; Frohman LA
    J Clin Endocrinol Metab; 2000 Feb; 85(2):707-14. PubMed ID: 10690880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
    Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
    Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An RFLP map for 2q33-q37 from multicase mycobacterial and leishmanial disease families: no evidence for an Lsh/Ity/Bcg gene homologue influencing susceptibility to leprosy.
    Shaw MA; Atkinson S; Dockrell H; Hussain R; Lins-Lainson Z; Shaw J; Ramos F; Silveira F; Mehdi SQ; Kaukab F
    Ann Hum Genet; 1993 Oct; 57(4):251-71. PubMed ID: 7910002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A genetic linkage study of familial breast-ovarian cancer.
    Ferrell RE; Anderson DE; Chidambaram A; Marino TR; Badzioch M
    Cancer Genet Cytogenet; 1989 Apr; 38(2):241-8. PubMed ID: 2720637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1.
    Kelsell DP; Black DM; Bishop DT; Spurr NK
    Hum Mol Genet; 1993 Nov; 2(11):1823-8. PubMed ID: 8281142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A radiation hybrid map of the BRCA1 region of chromosome 17q12-q21.
    Abel KJ; Boehnke M; Prahalad M; Ho P; Flejter WL; Watkins M; VanderStoep J; Chandrasekharappa SC; Collins FS; Glover TW
    Genomics; 1993 Sep; 17(3):632-41. PubMed ID: 8244380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Familial ovarian carcinoma: pedigree studies and preliminary results from linkage analysis.
    Sobol H; Mazoyer S; Smith SA; Lyonnet D; Bignon YJ; Narod SA; Ardoin A; Biron P; Bobin JY; Bremond A
    Bull Cancer; 1993 Feb; 80(2):121-34. PubMed ID: 8173163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hereditary and familial ovarian cancer in southern Ontario.
    Narod SA; Madlensky L; Bradley L; Cole D; Tonin P; Rosen B; Risch HA
    Cancer; 1994 Oct; 74(8):2341-6. PubMed ID: 7922985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exclusion of linkage between alcoholism and the MNS blood group region on chromosome 4q in multiplex families.
    Neiswanger K; Kaplan B; Hill SY
    Am J Med Genet; 1995 Feb; 60(1):72-9. PubMed ID: 7485239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic linkage mapping for a susceptibility locus to bipolar illness: chromosomes 2, 3, 4, 7, 9, 10p, 11p, 22, and Xpter.
    Detera-Wadleigh SD; Hsieh WT; Berrettini WH; Goldin LR; Rollins DY; Muniec D; Grewal R; Guroff JJ; Turner G; Coffman D
    Am J Med Genet; 1994 Sep; 54(3):206-18. PubMed ID: 7810578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exclusion of malignant hyperthermia susceptibility (MHS) from a putative MHS2 locus on chromosome 17q and of the alpha 1, beta 1, and gamma subunits of the dihydropyridine receptor calcium channel as candidates for the molecular defect.
    Sudbrak R; Golla A; Hogan K; Powers P; Gregg R; Du Chesne I; Lehmann-Horn F; Deufel T
    Hum Mol Genet; 1993 Jul; 2(7):857-62. PubMed ID: 8395939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Familial breast cancer.
    Steel CM; Cohen BB; Porter DE
    Semin Cancer Biol; 1992 Jun; 3(3):141-50. PubMed ID: 1511156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers.
    Aberle H; Bierkamp C; Torchard D; Serova O; Wagner T; Natt E; Wirsching J; Heidkämper C; Montagna M; Lynch HT
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6384-8. PubMed ID: 7604000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.